NEW YORK (GenomeWeb News) – Metabolomics company Molecular Biometrics said yesterday that it has completed a $12.5 million Series B financing.

New investor Atlas Ventures led the financing round with participation from existing investors Safeguard Scientifics and Oxford Bioscience Partners.

Based in Norwood, Mass., Molecular Biometrics will use the cash to accelerate the global launch of its lead product, ViaMetrics-E, a rapid, non-invasive procedure designed to enhance in vitro fertilization outcomes by using cellular metabolomic signatures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.